Richard C. Mulligan

52.1k total citations · 20 hit papers
202 papers, 41.2k citations indexed

About

Richard C. Mulligan is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Richard C. Mulligan has authored 202 papers receiving a total of 41.2k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Molecular Biology, 80 papers in Genetics and 56 papers in Immunology. Recurrent topics in Richard C. Mulligan's work include Virus-based gene therapy research (71 papers), RNA Interference and Gene Delivery (34 papers) and Immunotherapy and Immune Responses (32 papers). Richard C. Mulligan is often cited by papers focused on Virus-based gene therapy research (71 papers), RNA Interference and Gene Delivery (34 papers) and Immunotherapy and Immune Responses (32 papers). Richard C. Mulligan collaborates with scholars based in United States, France and Belgium. Richard C. Mulligan's co-authors include Daniel Ory, Katja Brose, Margaret A. Goodell, David Baltimore, G Paradis, Richard S. Mann, Philippe Gallay, Inder M. Verma, Ulrike Blömer and Didier Trono and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Richard C. Mulligan

200 papers receiving 39.8k citations

Hit Papers

In Vivo Gene Delivery and Stable Transduction of Nondiv... 1979 2026 1994 2010 1996 1993 1996 1983 1999 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
    1996 3.9k citations Richard C. Mulligan et al. Science profile →
  2. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
    1993 2.3k citations Glen Dranoff, Elizabeth M. Jaffee et al. Proceedings of the National Academy of Sciences profile →
  3. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
    1996 2.2k citations Katja Brose, Richard C. Mulligan et al. The Journal of Experimental Medicine profile →
  4. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus
    1983 1.6k citations Richard C. Mulligan et al. profile →
  5. Dystrophin expression in the mdx mouse restored by stem cell transplantation
    1999 1.4k citations Emanuela Gussoni, Corinne D. Strickland et al. Nature profile →
  6. The Basic Science of Gene Therapy
    1993 1.4k citations Richard C. Mulligan Science profile →
  7. "Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells
    2002 1.3k citations Yumi Matsuzaki, Richard C. Mulligan et al. Science profile →
  8. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
    1991 1.2k citations Richard C. Mulligan et al. profile →
  9. PTH/PTHrP Receptor in Early Development and Indian Hedgehog—Regulated Bone Growth
    1996 1.0k citations Richard C. Mulligan et al. Science profile →
  10. Engineering vascularized skeletal muscle tissue
    2005 963 citations Richard C. Mulligan et al. profile →
  11. Demonstration That CFTR Is a Chloride Channel by Alteration of Its Anion Selectivity
    1991 920 citations Matthew P. Anderson, Richard J. Gregory et al. Science profile →
  12. Construction and applications of a highly transmissible murine retrovirus shuttle vector
    1984 913 citations Richard C. Mulligan et al. profile →
  13. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene.
    1994 895 citations Roderick T. Bronson, Richard C. Mulligan et al. profile →
  14. Physiological consequences of loss of plasminogen activator gene function in mice
    1994 881 citations Peter Carmeliet, Luc Schoonjans et al. Nature profile →
  15. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species
    1997 879 citations Richard C. Mulligan et al. profile →
  16. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.
    1996 815 citations Richard C. Mulligan et al. Proceedings of the National Academy of Sciences profile →
  17. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges.
    1988 781 citations Richard C. Mulligan et al. Proceedings of the National Academy of Sciences profile →
  18. Developmental potential and dynamic behavior of hematopoietic stem cells
    1986 725 citations Richard C. Mulligan et al. profile →
  19. Involvement of Granulocyte-Macrophage Colony-Stimulating Factor in Pulmonary Homeostasis
    1994 694 citations Glenn Dranoff, Alexander D. Crawford et al. Science profile →
  20. Synthesis of rabbit β-globin in cultured monkey kidney cells following infection with a SV40 β-globin recombinant genome
    1979 283 citations Richard C. Mulligan, Paul Berg et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard C. Mulligan United States 85 23.1k 11.9k 8.6k 8.6k 4.0k 202 41.2k
Neal G. Copeland United States 135 42.7k 1.8× 12.3k 1.0× 8.0k 0.9× 13.6k 1.6× 2.8k 0.7× 622 73.1k
Nancy A. Jenkins United States 120 35.3k 1.5× 10.1k 0.8× 6.3k 0.7× 11.4k 1.3× 2.4k 0.6× 508 60.6k
Philip Leder United States 124 41.0k 1.8× 10.5k 0.9× 11.8k 1.4× 13.6k 1.6× 2.3k 0.6× 354 63.5k
David E. Housman United States 104 32.2k 1.4× 9.2k 0.8× 9.8k 1.1× 3.0k 0.4× 3.0k 0.7× 329 47.8k
Luigi Naldini Italy 99 29.0k 1.3× 17.4k 1.5× 9.1k 1.1× 7.0k 0.8× 3.0k 0.7× 309 43.6k
Uta Francke United States 99 24.1k 1.0× 14.5k 1.2× 5.0k 0.6× 4.8k 0.6× 2.4k 0.6× 503 41.9k
Frédéric J. de Sauvage United States 86 17.7k 0.8× 4.7k 0.4× 8.0k 0.9× 6.5k 0.8× 1.9k 0.5× 148 31.0k
Elaine Fuchs United States 151 37.7k 1.6× 6.6k 0.6× 8.3k 1.0× 7.0k 0.8× 3.8k 0.9× 391 69.0k
Carl‐Henrik Heldin Sweden 132 41.7k 1.8× 4.7k 0.4× 14.1k 1.6× 5.9k 0.7× 4.5k 1.1× 494 62.7k
Leonard D. Shultz United States 92 10.5k 0.5× 5.4k 0.4× 7.9k 0.9× 14.0k 1.6× 3.6k 0.9× 452 32.2k

Countries citing papers authored by Richard C. Mulligan

Since Specialization
Citations

This map shows the geographic impact of Richard C. Mulligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard C. Mulligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard C. Mulligan more than expected).

Fields of papers citing papers by Richard C. Mulligan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard C. Mulligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard C. Mulligan. The network helps show where Richard C. Mulligan may publish in the future.

Co-authorship network of co-authors of Richard C. Mulligan

This figure shows the co-authorship network connecting the top 25 collaborators of Richard C. Mulligan. A scholar is included among the top collaborators of Richard C. Mulligan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard C. Mulligan. Richard C. Mulligan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grant, Julia D., et al.. (2015). Familial influences on the full range of variability in attention and activity levels during adolescence: A longitudinal twin study. Development and Psychopathology. 28(2). 517–526. 6 indexed citations
2.
Mulligan, Richard C., Angela M. Reiersen, & Alexandre A. Todorov. (2013). Attention-Deficit/Hyperactivity Disorder, Autistic Traits, and Substance Use Among Missouri Adolescents. SHILAP Revista de lepidopterología. 2(2). 86–92. 10 indexed citations
3.
Austin, Karyn M., Mohan L. Gupta, Scott A. Coats, et al.. (2008). Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. Journal of Clinical Investigation. 118(4). 1511–1518. 95 indexed citations
4.
Glodek, Aleksandra M., Yi Le, Derek M. Dykxhoorn, et al.. (2007). Focal adhesion kinase is required for CXCL12-induced chemotactic and pro-adhesive responses in hematopoietic precursor cells. Leukemia. 21(8). 1723–1732. 53 indexed citations
5.
Mostoslavsky, Gustavo, Attila J. Fabian, Seán Rooney, Frederick W. Alt, & Richard C. Mulligan. (2006). Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer. Proceedings of the National Academy of Sciences. 103(44). 16406–16411. 129 indexed citations
6.
Yen, Laising, Jennifer M. Svendsen, Jeng-Shin Lee, et al.. (2004). Exogenous control of mammalian gene expression through modulation of RNA self-cleavage. Nature. 431(7007). 471–476. 210 indexed citations
7.
Matsuzaki, Yumi, Kentaro Kinjo, Richard C. Mulligan, & Hideyuki Okano. (2004). Unexpectedly Efficient Homing Capacity of Purified Murine Hematopoietic Stem Cells. Immunity. 20(1). 87–93. 224 indexed citations
8.
Nelson, William G., Jonathan W. Simons, Bahar Mikhak, et al.. (2000). Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies. Cancer Chemotherapy and Pharmacology. 46(S1). S67–S72. 62 indexed citations
9.
Gussoni, Emanuela, Corinne D. Strickland, Elizabeth A. Buzney, et al.. (1999). . Nature. 401(6751). 390–394. 50 indexed citations
10.
Simons, J.W., Elizabeth M. Jaffee, William G. Nelson, et al.. (1998). Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by Ex Vivo Granulocyte-Macrophage Colony-Stimulating Factor Gene Transfer. The Journal of Urology. 159(2S). 617–618. 61 indexed citations
11.
Mulligan, Richard C., et al.. (1995). Gene Transfer as Cancer Therapy. Advances in immunology. 58. 417–454. 110 indexed citations
12.
Carmeliet, Peter, Richard C. Mulligan, & D Collen. (1994). Transgenic animals as tools for the study of fibrinolysis in vivo. Journal of Internal Medicine. 236(4). 455–459. 7 indexed citations
13.
Shworak, Nicholas W., Sylvia Colliec‐Jouault, Jing Liu, et al.. (1994). Pathway-specific regulation of the synthesis of anticoagulantly active heparan sulfate.. Journal of Biological Chemistry. 269(40). 24941–24952. 64 indexed citations
14.
Dranoff, Glenn, Alexander D. Crawford, Michel Sadelain, et al.. (1994). Involvement of Granulocyte-Macrophage Colony-Stimulating Factor in Pulmonary Homeostasis. Science. 264(5159). 713–716. 694 indexed citations breakdown →
15.
Carmeliet, Peter, L Kieckens, Luc Schoonjans, et al.. (1993). Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.. Journal of Clinical Investigation. 92(6). 2746–2755. 292 indexed citations
16.
Dranoff, Glen, Elizabeth M. Jaffee, A Lazenby, et al.. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.. Proceedings of the National Academy of Sciences. 90(8). 3539–3543. 2310 indexed citations breakdown →
17.
Berger, Herbert A., Matthew P. Anderson, Richard J. Gregory, et al.. (1991). Identification and regulation of the cystic fibrosis transmembrane conductance regulator-generated chloride channel.. Journal of Clinical Investigation. 88(4). 1422–1431. 208 indexed citations
18.
Robbins, Paul D., Jonathan M. Horowitz, & Richard C. Mulligan. (1991). Correction: Negative regulation of human c-fos expression by the retinoblastoma gene product. Nature. 351(6325). 419–419. 2 indexed citations
19.
Williams, David A., et al.. (1987). Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow.. The Journal of Experimental Medicine. 166(1). 210–218. 120 indexed citations
20.
Mulligan, Richard C. & Paul Berg. (1981). Factors Governing the Expression of a Bacterial Gene in Mammalian Cells. Molecular and Cellular Biology. 1(5). 449–459. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neal G. Copeland Breakdown of academic impact, for papers by Nancy A. Jenkins Breakdown of academic impact, for papers by Philip Leder Breakdown of academic impact, for papers by David E. Housman Breakdown of academic impact, for papers by Luigi Naldini Breakdown of academic impact, for papers by Uta Francke Breakdown of academic impact, for papers by Frédéric J. de Sauvage Breakdown of academic impact, for papers by Elaine Fuchs Breakdown of academic impact, for papers by Carl‐Henrik Heldin Breakdown of academic impact, for papers by Leonard D. Shultz
Rankless by CCL
2026